Latest Breaking News On - Allen davidoff - Page 1 : vimarsana.com

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

XORTX Reprices Warrants Issued in Connection with Previous

CALGARY, Alberta, April 30, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

Money Talk Radio with Ellis Martin: XORTX Therapeutics Inc. (NASDAQ:XRTX) (CVE:XRTX) Dr. Allen Davidoff-Look for More M&As in the Kidney Disease Remediation Space in the Future

In this segment of Money Talk Radio with Ellis Martin, we speak with Dr. Allen Davidoff, CEO of XORTX Therapeutics (NASDAQ:XRTX) (CVE:XRTX), a pioneer in developing new therapies for progressive kidney disease and diabetes.

XORTX Announces Publication of Key Research in ADPKD

XORTX Announces Participation in Spring 2024 Investor Conferences

XORTX Therapeutics : CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K -April 04, 2024 at 06:04 am EDT

CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEARS ENDED DECEMBER 31, 2023, 2022 and 2021 REPORT OF INDEPENDENT REGISTERED PUBLIC...

XORTX Announces New Clinical Advisory Board Member

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (

XORTX Announces New Clinical Advisory Board Member - XORTX Therapeutics (NASDAQ:XRTX)

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANUA WKN: A3UNZ)), a biopharmaceutical company focused on developing

XORTX Therapeutics Inc (XRTX) Appoints Ronald Perrone to its Board